{"id":90,"date":"2026-02-22T23:06:06","date_gmt":"2026-02-22T23:06:06","guid":{"rendered":"https:\/\/legacyantibodies.com\/?page_id=90"},"modified":"2026-03-19T11:15:13","modified_gmt":"2026-03-19T11:15:13","slug":"service-three","status":"publish","type":"page","link":"https:\/\/legacyantibodies.com\/en\/service-three\/","title":{"rendered":"Service Three"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Header&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; use_background_color_gradient=&#8221;on&#8221; background_color_gradient_stops=&#8221;rgba(31,35,44,0.7) 0%|gcid-9fa4a1b6-767d-41ca-984c-a6f10449c843 100%&#8221; background_color_gradient_overlays_image=&#8221;on&#8221; background_enable_image=&#8221;off&#8221; locked=&#8221;off&#8221; collapsed=&#8221;on&#8221; global_colors_info=&#8221;{%22gcid-9fa4a1b6-767d-41ca-984c-a6f10449c843%22:%91%22background_color_gradient_stops%22%93}&#8221;][et_pb_row _builder_version=&#8221;4.20.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.20.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;f1f50a53-fc30-4e5f-b383-c94c8557ca4d&#8221; header_4_text_color=&#8221;gcid-2f3f3e09-0a26-4ea7-8906-5e1128945e3f&#8221; text_orientation=&#8221;center&#8221; custom_margin=&#8221;||10px||false|false&#8221; global_colors_info=&#8221;{%22gcid-2f3f3e09-0a26-4ea7-8906-5e1128945e3f%22:%91%22header_4_text_color%22%93}&#8221;]<\/p>\n<h4>Services<\/h4>\n<p>[\/et_pb_text][et_pb_image src=&#8221;https:\/\/legacyantibodies.com\/wp-content\/uploads\/2026\/02\/attorney-1.png&#8221; title_text=&#8221;attorney-1&#8243; _builder_version=&#8221;4.20.0&#8243; _module_preset=&#8221;default&#8221; max_width=&#8221;130px&#8221; module_alignment=&#8221;center&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;961f5926-5eb3-4df9-886d-bb8dd7e18705&#8243; header_text_color=&#8221;#C6C6C6&#8243; text_orientation=&#8221;center&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h1>Recombinant Antibodies<\/h1>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Service Info&#8221; _builder_version=&#8221;4.20.0&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;gcid-9fa4a1b6-767d-41ca-984c-a6f10449c843&#8243; collapsed=&#8221;on&#8221; global_colors_info=&#8221;{%22gcid-9fa4a1b6-767d-41ca-984c-a6f10449c843%22:%91%22background_color%22%93}&#8221;][et_pb_row custom_padding_last_edited=&#8221;on|desktop&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;30px|60px|30px|60px|true|true&#8221; custom_padding_tablet=&#8221;|40px||40px|false|true&#8221; custom_padding_phone=&#8221;20px|20px|20px|20px|true|true&#8221; border_color_all=&#8221;#848484&#8243; border_width_left=&#8221;5px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.20.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;7b6a772b-c512-494f-99be-a3cfe0b8ba63&#8243; header_3_text_color=&#8221;#C6C6C6&#8243; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>The final evolution<\/h3>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;9aef31f7-d184-49bb-bc05-0914345a9939&#8243; text_text_color=&#8221;#FFFFFF&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>Recombinant antibodies are the most secure method of production in terms of supply chain and the larger scales required as you head into advanced or clinical stages.\u00a0 If you know you will need a recombinant but are still in the Discovery stage, you typically will need to start with polyclonal and monoclonal steps to isolate the sequence of the antibody you will ultimately produce.<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,3_4&#8243; _builder_version=&#8221;4.20.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.20.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;1de6e2aa-181c-4aca-a357-e0e59458cce0&#8243; header_4_text_color=&#8221;#C6C6C6&#8243; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Ad Hoc production<\/h4>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;3_4&#8243; _builder_version=&#8221;4.20.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;9aef31f7-d184-49bb-bc05-0914345a9939&#8243; text_text_color=&#8221;#FFFFFF&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>If you have already isolated the VH\/VL sequences elsewhere but would like to produce the recombinant with us, we can help!\u00a0 Some of the things we need to know in addition to the sequences are:<\/p>\n<p>Original species and IgG subtype<\/p>\n<p>Preferred cell line (typically HEK293 or CHO, but others available)<\/p>\n<p>Required scale<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,3_4&#8243; _builder_version=&#8221;4.20.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.20.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;1de6e2aa-181c-4aca-a357-e0e59458cce0&#8243; header_4_text_color=&#8221;#C6C6C6&#8243; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Antibody Engineering<\/h4>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;3_4&#8243; _builder_version=&#8221;4.20.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;9aef31f7-d184-49bb-bc05-0914345a9939&#8243; text_text_color=&#8221;#FFFFFF&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>It is possible and relatively straightforward to do limited engineering steps such as IgG class switching or changing the constant region from one species to another (including humanization).\u00a0<\/p>\n<p>We have not tried mutational engineering or other more highly specialized sequence changes to date, and as of right now the permutations involved could make this rather expensive.\u00a0 As modeling capabilities improve, however, it is certainly possible this avenue may open up for all of us in the future.<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Footer&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; use_background_color_gradient=&#8221;on&#8221; background_color_gradient_stops=&#8221;#1e232b 0%|rgba(30,35,43,0.9) 100%&#8221; background_color_gradient_overlays_image=&#8221;on&#8221; background_enable_image=&#8221;off&#8221; saved_tabs=&#8221;all&#8221; locked=&#8221;off&#8221; collapsed=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;1_3,1_3,1_3&#8243; _builder_version=&#8221;4.20.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.20.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;370b430b-b3b2-4e61-8111-d9ef05ce5ad6&#8243; header_4_text_color=&#8221;#C6C6C6&#8243; text_orientation=&#8221;center&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Office Hours<\/h4>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;2023cf4b-5667-411c-ac82-879e66de99ac&#8221; text_text_color=&#8221;#FFFFFF&#8221; text_orientation=&#8221;center&#8221; custom_margin=&#8221;||10px||false|false&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>M &#8211; F 7:00 am to 4:00 pm (ET)<\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.20.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/legacyantibodies.com\/wp-content\/uploads\/2026\/03\/Logo-final.png&#8221; title_text=&#8221;Logo final&#8221; align=&#8221;center&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; max_height=&#8221;90px&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.20.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;370b430b-b3b2-4e61-8111-d9ef05ce5ad6&#8243; header_4_text_color=&#8221;#C6C6C6&#8243; text_orientation=&#8221;center&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Contact Info<\/h4>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;2023cf4b-5667-411c-ac82-879e66de99ac&#8221; text_text_color=&#8221;#FFFFFF&#8221; link_text_color=&#8221;#FFFFFF&#8221; text_orientation=&#8221;center&#8221; link_option_url=&#8221;https:\/\/maps.app.goo.gl\/CaoyZMXxzzU1jd8o6&#8243; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>2 Shaker Rd., Suite B203<\/p>\n<p>Shirley, MA 01464<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;2023cf4b-5667-411c-ac82-879e66de99ac&#8221; text_text_color=&#8221;#FFFFFF&#8221; link_text_color=&#8221;#FFFFFF&#8221; text_orientation=&#8221;center&#8221; custom_margin=&#8221;||10px||false|false&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><a href=\"tel:+15089227719\">+1 (508) 922-7719<\/a><\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;2023cf4b-5667-411c-ac82-879e66de99ac&#8221; text_text_color=&#8221;#FFFFFF&#8221; link_text_color=&#8221;#FFFFFF&#8221; text_orientation=&#8221;center&#8221; custom_margin=&#8221;||10px||false|false&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><a href=\"mailto:scottedwinlewis4@gmail.com\">scott@legacyantibodies.com<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.20.0&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;0px||0px||true|&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.20.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_social_media_follow icon_color=&#8221;#000000&#8243; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_orientation=&#8221;center&#8221; custom_margin=&#8221;||||false|false&#8221; hover_enabled=&#8221;0&#8243; border_radii=&#8221;on|100px|100px|100px|100px&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;][et_pb_social_media_follow_network social_network=&#8221;linkedin&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#848484&#8243; background_enable_color=&#8221;on&#8221; custom_padding=&#8221;8px|8px|8px|8px|true|true&#8221; global_colors_info=&#8221;{}&#8221; follow_button=&#8221;off&#8221; url_new_window=&#8221;on&#8221; url=&#8221;https:\/\/www.linkedin.com\/company\/legacy-antibodies-llc&#8221; hover_enabled=&#8221;0&#8243; sticky_enabled=&#8221;0&#8243;]linkedin[\/et_pb_social_media_follow_network][\/et_pb_social_media_follow][et_pb_divider color=&#8221;#848484&#8243; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_divider][et_pb_text _builder_version=&#8221;4.27.5&#8243; _dynamic_attributes=&#8221;content&#8221; _module_preset=&#8221;84a07382-e7a7-4f9c-845a-4ad31f3c7af8&#8243; text_text_color=&#8221;#FFFFFF&#8221; text_orientation=&#8221;center&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoiY3VycmVudF9kYXRlIiwic2V0dGluZ3MiOnsiYmVmb3JlIjoiQ29weXJpZ2h0ICZjb3B5OyAiLCJhZnRlciI6IiBMZWdhY3kgQW50aWJvZGllcy4gQWxsIFJpZ2h0cyBSZXNlcnZlZC4iLCJkYXRlX2Zvcm1hdCI6ImN1c3RvbSIsImN1c3RvbV9kYXRlX2Zvcm1hdCI6IlkifX0=@[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>ServicesRecombinant AntibodiesThe final evolutionRecombinant antibodies are the most secure method of production in terms of supply chain and the larger scales required as you head into advanced or clinical stages.\u00a0 If you know you will need a recombinant but are still in the Discovery stage, you typically will need to start with polyclonal and monoclonal [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"<!-- wp:divi\/placeholder \/-->","_et_gb_content_width":"","footnotes":""},"class_list":["post-90","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Service Three - Legacy Antibodies<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/legacyantibodies-m74vhbtrik.live-website.com\/service-three\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Service Three - Legacy Antibodies\" \/>\n<meta property=\"og:description\" content=\"ServicesRecombinant AntibodiesThe final evolutionRecombinant antibodies are the most secure method of production in terms of supply chain and the larger scales required as you head into advanced or clinical stages.\u00a0 If you know you will need a recombinant but are still in the Discovery stage, you typically will need to start with polyclonal and monoclonal [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/legacyantibodies-m74vhbtrik.live-website.com\/service-three\/\" \/>\n<meta property=\"og:site_name\" content=\"Legacy Antibodies\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-19T11:15:13+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/legacyantibodies-m74vhbtrik.live-website.com\\\/service-three\\\/\",\"url\":\"https:\\\/\\\/legacyantibodies-m74vhbtrik.live-website.com\\\/service-three\\\/\",\"name\":\"Service Three - Legacy Antibodies\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/legacyantibodies-m74vhbtrik.live-website.com\\\/#website\"},\"datePublished\":\"2026-02-22T23:06:06+00:00\",\"dateModified\":\"2026-03-19T11:15:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/legacyantibodies-m74vhbtrik.live-website.com\\\/service-three\\\/#breadcrumb\"},\"inLanguage\":\"en\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/legacyantibodies-m74vhbtrik.live-website.com\\\/service-three\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/legacyantibodies-m74vhbtrik.live-website.com\\\/service-three\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/legacyantibodies.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Service Three\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/legacyantibodies-m74vhbtrik.live-website.com\\\/#website\",\"url\":\"https:\\\/\\\/legacyantibodies-m74vhbtrik.live-website.com\\\/\",\"name\":\"Legacy Antibodies\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/legacyantibodies-m74vhbtrik.live-website.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Service Three - Legacy Antibodies","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/legacyantibodies-m74vhbtrik.live-website.com\/service-three\/","og_locale":"en_US","og_type":"article","og_title":"Service Three - Legacy Antibodies","og_description":"ServicesRecombinant AntibodiesThe final evolutionRecombinant antibodies are the most secure method of production in terms of supply chain and the larger scales required as you head into advanced or clinical stages.\u00a0 If you know you will need a recombinant but are still in the Discovery stage, you typically will need to start with polyclonal and monoclonal [&hellip;]","og_url":"https:\/\/legacyantibodies-m74vhbtrik.live-website.com\/service-three\/","og_site_name":"Legacy Antibodies","article_modified_time":"2026-03-19T11:15:13+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/legacyantibodies-m74vhbtrik.live-website.com\/service-three\/","url":"https:\/\/legacyantibodies-m74vhbtrik.live-website.com\/service-three\/","name":"Service Three - Legacy Antibodies","isPartOf":{"@id":"https:\/\/legacyantibodies-m74vhbtrik.live-website.com\/#website"},"datePublished":"2026-02-22T23:06:06+00:00","dateModified":"2026-03-19T11:15:13+00:00","breadcrumb":{"@id":"https:\/\/legacyantibodies-m74vhbtrik.live-website.com\/service-three\/#breadcrumb"},"inLanguage":"en","potentialAction":[{"@type":"ReadAction","target":["https:\/\/legacyantibodies-m74vhbtrik.live-website.com\/service-three\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/legacyantibodies-m74vhbtrik.live-website.com\/service-three\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/legacyantibodies.com\/"},{"@type":"ListItem","position":2,"name":"Service Three"}]},{"@type":"WebSite","@id":"https:\/\/legacyantibodies-m74vhbtrik.live-website.com\/#website","url":"https:\/\/legacyantibodies-m74vhbtrik.live-website.com\/","name":"Legacy Antibodies","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/legacyantibodies-m74vhbtrik.live-website.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en"}]}},"_links":{"self":[{"href":"https:\/\/legacyantibodies.com\/en\/wp-json\/wp\/v2\/pages\/90","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/legacyantibodies.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/legacyantibodies.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/legacyantibodies.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/legacyantibodies.com\/en\/wp-json\/wp\/v2\/comments?post=90"}],"version-history":[{"count":12,"href":"https:\/\/legacyantibodies.com\/en\/wp-json\/wp\/v2\/pages\/90\/revisions"}],"predecessor-version":[{"id":482,"href":"https:\/\/legacyantibodies.com\/en\/wp-json\/wp\/v2\/pages\/90\/revisions\/482"}],"wp:attachment":[{"href":"https:\/\/legacyantibodies.com\/en\/wp-json\/wp\/v2\/media?parent=90"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}